achondroplasia

Veradigm

Pharma

For $100M, BridgeBio partners with Kyowa Kirin on infigratinib

With an upfront payment of $100 million, Kyowa Kirin has bought into a partnership with BridgeBio to develop and commercialize infigratinib in Japan.

Kevin Dunleavy Feb 7, 2024 12:53pm

Jean-Jacques Bienaime

BioMarin on its way to turning a profit in 2022

Apr 28, 2022 9:50am